TIMP1 and gastric cancer: TIMP-1 expression has also been reported to be associated with adverse pathologic features and poor prognostic factors in different types of cancer, including nonsmall cell lung cancer, colorectal cancer, gastric cancer, and childhood acute lymphoblastic leukemia [23–30].